preferred drug

A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...

Hansae Yes24 Holdings Co., the holding company of South Korea’s leading apparel original equipment manufacturer (OEM) Hansae Co., has moved a ...

South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...

The holding company of Hansae Co., a leading global apparel original equipment manufacturer (OEM), is eyeing expansion into auto parts production by...

Woojin Industrial Systems Co., a South Korean railway vehicle manufacturer, said on Friday that it has been selected as the preferred bidder for the...

South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...

Financial investors of Qxpress Pte. are set to take over Singapore-based Qoo10 Pte. and its founder Ku Young Bae’s control amid financial turm...

South Korea's Hanwha Ocean Co. announced on Thursday that it was selected as the preferred bidder for the second auxiliary oiler replenishment (AOE)...

South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a techno...

South Korea’s Hyosung Group is poised to sell a 100% stake in its specialty and industrial gas unit to a consortium led by IMM Private Equity ...

South Korea’s Public Officials Benefit Association (POBA) is set to commit 150 billion won ($108.5 million) in preferred stocks for offices in...

More South Korean information technology companies are seeking engineers with business capabilities as artificial intelligence is expected to take o...

Seoul-based private equity firm Q Capital Partners seeks to buy a 39.3% stake with management rights in South Korean drama series producer Chorokbae...

SAN DIEGO, California -- South Korea’s SK Biopharmaceuticals Co. is considering acquiring firms in the US, or the sales rights to some of thei...

South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...

The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...

Hyundai Motor Group, the world’s third-largest automaker, is set to spend nearly $1 billion on Motional, its loss-making self-driving joint ve...

South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...

Private equity giant Blackstone Inc. is set to mark its first exit from South Korea by selling a 71.25% stake in the holding firm of Geo-Young Corp....

Singapore’s Keppel REIT Management Ltd. is set to divest of its Seoul-based prime office building T Tower near Seoul Station.Real estate manag...

Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...

Boryung Corp., formerly Boryung Pharmaceutical Co., aims to join the 1 trillion won ($748 million) sales club this year, driven by new chronic disea...

Hyundai Engineering & Construction Co. (Hyundai E&C) announced on Monday that it was selected as the preferred bidder for a private invest...

South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...

South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., announced on Sunday that it plans to develop a government-wide hyperscal...

Canada’s Brookfield Asset Management Ltd. has selected Seoul-based real estate manager ARA Korea Ltd. as the preferred bidder for five-star ho...

South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...

South Korea's SK Biopharmaceuticals targeted 416 billion won ($311 million) for its epilepsy treatment Cenobamate in the US market this year. SK Bi...